Search results for "arki"

showing 10 items of 1015 documents

Benefits of nonlinear analysis indices of walking stride interval in the evaluation of neurodegenerative diseases.

2021

Indices characterising the long-range temporal structure of walking stride interval (SI) variability such as Hurst exponent (H) and fractal dimension (D) may be used in addition to indices measuring the amount of variability like the coefficient of variation (CV). We assess the added value of the former indices in a clinical neurological context. Our aim is to demonstrate that they provide a clinical significance in aging and in frequent neurodegenerative diseases such as Parkinson's disease, Huntington, and amyotrophic lateral sclerosis. Indices assessing the temporal structure of variability are mainly dependent on SI time series length and algorithms used, making quantitative comparisons…

AdultMalemedicine.medical_specialtyAgingCoefficient of variationBiophysicsSTRIDEExperimental and Cognitive PsychologyContext (language use)DiseaseWalkingPhysical medicine and rehabilitationmedicineHumansOrthopedics and Sports MedicineClinical significanceAmyotrophic lateral sclerosisGaitHurst exponentPrincipal Component Analysisbusiness.industryNeurodegenerative DiseasesParkinson DiseaseGeneral MedicineMiddle Agedmedicine.diseaseFractalsHuntington DiseaseGait analysisFemalebusinessGait AnalysisAlgorithmsHuman movement science
researchProduct

Normative vs. patient-specific brain connectivity in deep brain stimulation

2020

Abstract Brain connectivity profiles seeding from deep brain stimulation (DBS) electrodes have emerged as informative tools to estimate outcome variability across DBS patients. Given the limitations of acquiring and processing patient-specific diffusion-weighted imaging data, a number of studies have employed normative atlases of the human connectome. To date, it remains unclear whether patient-specific connectivity information would strengthen the accuracy of such analyses. Here, we compared similarities and differences between patient-specific, disease-matched and normative structural connectivity data and their ability to predict clinical improvement. Data from 33 patients suffering from…

AdultMalemedicine.medical_specialtyDeep brain stimulationParkinson's diseaseCognitive Neurosciencemedicine.medical_treatmentSubthalamic nucleusImaging data050105 experimental psychologylcsh:RC321-57103 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationConnectomeDeep brain stimulationmedicineHumans0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBrain MappingModalitiesbusiness.industry05 social sciencesBrainHuman ConnectomeMiddle AgedPatient specificMagnetic Resonance ImagingHuman connectomeNeurologyConnectomeNormativeFemalebusinessTractography030217 neurology & neurosurgeryTractographyNeuroImage
researchProduct

Switching on the deep brain stimulation: effects on cardiovascular regulation and respiration.

2011

Abstract Background Objective of this study was to evaluate the acute cardiovascular and respiratory effects of switching on the deep brain stimulation in the follow up of nine Parkinson's disease patients with subthalamic nucleus stimulation and six cluster headache patients with posterior hypothalamic area stimulation. Methods Systolic and diastolic blood pressure, heart rate, and respiratory rate were monitored continuously during supine rest in both groups. Each patient was assessed in two conditions: resting supine with stimulator off and with stimulator on. Results In supine resting condition switching on the DBS induced no significant changes ( p  > 0.05) in systolic and diastolic bl…

AdultMalemedicine.medical_specialtyDeep brain stimulationSupine positionRespiratory ratemedicine.medical_treatmentDeep Brain StimulationStimulationCluster HeadacheCardiovascularCardiovascular Physiological PhenomenaCellular and Molecular NeuroscienceCardiovascular Deep brain stimulation Blood pressure Heart rate Respiratory Parkinson ClusterInternal medicineHeart rateMedicineHumansParkinsonRespiratory systemAgedHEART RATEEndocrine and Autonomic Systemsbusiness.industryCluster headacheParkinson DiseaseMiddle Agedmedicine.diseaseElectrodes ImplantedBlood pressureClusterAnesthesiaBlood pressureRespiratoryCardiologyRespiratory Physiological PhenomenaFemaleNeurology (clinical)businessFollow-Up StudiesAutonomic neuroscience : basicclinical
researchProduct

Exploring recollection and familiarity impairments in Parkinson’s disease

2014

There is conflicting evidence on whether patients diagnosed with Parkinson's disease (PD) have cognitive deficits associated with episodic memory and particularly with recognition memory. The aim of the present study was to explore whether PD patients exhibit deficits in recollection and familiarity, the two processes involved in recognition. A sample of young healthy participants (22) was tested to verify that the experimental tasks were useful estimators of recognition processes. Two further samples ¿ one of elderly controls (16) and one of PD patients (20) ¿ were the main focus of this research. All participants were exposed to an associative recognition task aimed at estimating recollec…

AdultMalemedicine.medical_specialtyParkinson's diseaseAdolescentDiseaseNeuropsychological TestsAudiologyDevelopmental psychologyYoung AdultmedicineHumansYoung adultEpisodic memoryAgedRecognition memoryAged 80 and overMemory DisordersRecallParkinson DiseaseRecognition PsychologyCognitionMiddle Agedmedicine.diseaseTest (assessment)Clinical PsychologyNeurologyMental RecallFemaleNeurology (clinical)Malalties mentalsPsychologyJournal of Clinical and Experimental Neuropsychology
researchProduct

A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease

2003

<i>Objective:</i> To investigate the association between cigarette smoking, alcohol drinking, coffee consumption and Parkinson’s disease (PD). <i>Methods:</i> We selected subjects affected by idiopathic PD, with a Mini-Mental State Examination of ≧24, and controls matched 1 to 1 with cases by age (± 2 years) and sex. Controls were randomly selected from the resident list of the same municipality of residence of the cases. We assessed cigarette smoking, alcohol drinking, and coffee consumption preceding the onset of PD or the corresponding time for controls using a structured questionnaire, which also evaluated the duration and dose of exposure. Using conditional logi…

AdultMalemedicine.medical_specialtyParkinson's diseaseAlcohol DrinkingEpidemiologyParkinson's diseaseAlcoholCoffee consumptionDiseaseNeuropsychological TestsCoffeechemistry.chemical_compoundCigarette smokingEnvironmental healthEpidemiologymedicineOdds RatioHumansCigaretteAgedAged 80 and overbusiness.industrySmokingCase-control studyParkinson DiseaseOdds ratioMiddle Agedmedicine.diseasechemistryItalyRisk factorsCase-Control StudiesRegression AnalysisFemaleNeurology (clinical)businessAlcohol
researchProduct

Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.

2008

Myocardial (123)Metaiodobenzylguanidine (MIBG) enables the assessment of postganglionic sympathetic cardiac innervation. MIBG uptake is decreased in nearly all patients with Parkinson's disease (PD). Our objective was to evaluate MIBG uptake in patients with genetic PD. We investigated MIBG uptake in 14 patients with PD associated with mutations in different genes (Parkin, DJ-1, PINK], and leucine-rich repeat kinase 2 -LRRK2), in 15 patients with idiopathic PD, and 10 control subjects. The myocardial MIGB uptake was preserved in 3 of the 4 Parkin-associated Parkinsonisms, in I of the 2 patients with DJ-1 mutations, in 1 of the 2 brothers with PINK] mutations, in 3 of the 6 unrelated patient…

AdultMalemedicine.medical_specialtyParkinson's diseaseGenotypeUbiquitin-Protein LigasesDNA Mutational AnalysisProtein Deglycase DJ-1PINK1Gene mutationProtein Serine-Threonine Kinasesmedicine.disease_causeLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Severity of Illness IndexParkinCentral nervous system diseaseDiagnosis DifferentialDegenerative diseaseParkinsonian DisordersInternal medicineSurveys and QuestionnairesmedicineHumansPoint MutationPromoter Regions GeneticGenetic PD Myocardial scintigraphyOncogene ProteinsTomography Emission-Computed Single-PhotonMutationMovement Disordersbusiness.industryMyocardiumIntracellular Signaling Peptides and ProteinsParkinson DiseaseGalvanic Skin ResponseMiddle Agedmedicine.diseaseLRRK2nervous system diseases3-IodobenzylguanidineEndocrinologyNeurologySettore MED/26 - NeurologiaFemaleNeurology (clinical)RadiopharmaceuticalsbusinessProtein KinasesMovement disorders : official journal of the Movement Disorder Society
researchProduct

BODY MASS INDEX DOES NOT CHANGE BEFORE PARKINSON'S DISEASE ONSET.

2008

Background and purpose:  Previous studies on the association between Parkinson’s disease (PD) and body mass index (BMI) have reported conflicting results. We investigated the relationship between PD and BMI by a case–control study. Methods:  PD patients were randomly matched to healthy individuals by sex and age. BMI distribution in cases has been compared with BMI of controls and odd ratios (ORs) with 95% CI were calculated. Results:  We included 318 PD patients and 318 controls. We observed no association between PD and BMI. BMI distribution in cases and controls was similar also when we adjusted for diabetes, hypercholesterolemia and the time elapsed between PD onset and the interview (O…

AdultMalemedicine.medical_specialtyParkinson's diseaseHypercholesterolemiaPopulationComorbidityWeight GainCoffeeBody Mass IndexRisk FactorsInternal medicineDiabetes mellitusWeight LossEpidemiologyDiabetes MellitusmedicineHumansObesityAge of OnseteducationAgedAged 80 and overHypertriglyceridemiaeducation.field_of_studybusiness.industrySmokingCase-control studynutritional and metabolic diseasesParkinson DiseaseMiddle AgedOverweightmedicine.diseaseNeurologyCase-Control StudiesHealthy individualsanthropometrical measures body mass index case–control study epidemiology Parkinson's disease risk factorsPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessBody mass index
researchProduct

The neuropsychological profile of Othello syndrome in Parkinson's disease.

2017

AdultMalemedicine.medical_specialtyParkinson's diseaseIndolesCognitive Neurosciencemedia_common.quotation_subjectSexual BehaviorJealousyExperimental and Cognitive PsychologyNeuropsychological Tests050105 experimental psychologyDelusionsAntiparkinson Agents03 medical and health sciences0302 clinical medicineJealousyDopaminemedicineHumans0501 psychology and cognitive sciencesPsychiatrymedia_common05 social sciencesNeuropsychologyParkinson DiseaseMiddle Agedmedicine.diseaseNeuropsychology and Physiological PsychologyStroop TestFemalePsychology030217 neurology & neurosurgerymedicine.drugClinical psychologyCortex; a journal devoted to the study of the nervous system and behavior
researchProduct

Elevated [18F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease

2010

Udgivelsesdato: 2010-Feb-15 PET studies with the DOPA decarboxylase substrate 6-[(18)F]fluoro-l-DOPA (FDOPA) reveal the storage of [(18)F]-fluorodopamine within synaptic vesicles, mainly of dopamine fibres. As such, FDOPA PET is a sensitive indicator of the integrity of the nigrostriatal dopamine innervation. Nonetheless, there have been several reports of focal elevations of FDOPA utilization in brain of patients with Parkinson's disease (PD), all based on reference tissue methods. To investigate this phenomenon further, we used voxel-wise steady-state kinetic analysis to search for regions of elevated FDOPA utilization (K; ml g(-1) min(-1)) and steady-state trapping (V(d); ml g(-1)) in a …

AdultMalemedicine.medical_specialtyParkinson's diseaseMetabolic Clearance RateCognitive NeuroscienceStriatumNucleus accumbensPeriaqueductal grayNucleus AccumbensDopamineInternal medicinemedicineHumansPeriaqueductal GrayAgedAromatic L-amino acid decarboxylasebusiness.industryParkinsonismPutamenParkinson DiseaseMiddle Agedmedicine.diseaseDihydroxyphenylalanineEndocrinologyNeurologyPositron-Emission TomographyFemaleRadiopharmaceuticalsbusinessNeurosciencemedicine.drugNeuroImage
researchProduct

How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire.

2008

We used a CAPSIT-based questionnaire to estimate the percentage of parkinsonian patients suitable for subthalamic nucleus (STN) deep brain stimulation (DBS) in a movement disorders clinic. We found that out of 641 consecutive PD patients only 1.6% fulfilled strict STN-DBS criteria. When we applied more flexible criteria, the percentage of eligibility increased to 4.5%. Most patients (60%) were ineligible because they did not satisfy multiple questionnaire items. Items related to disease severity were responsible for the largest number of exclusions. This knowledge will help make decisions on resource allocation in centres wishing to start DBS surgery.

AdultMalemedicine.medical_specialtyParkinson's diseaseMovement disordersNeurologyDeep brain stimulationDeep Brain Stimulationmedicine.medical_treatmentParkinson Desease Deep Brain StimulationAudiologybehavioral disciplines and activitiesDisease severityParkinsonian DisordersSubthalamic NucleusSurveys and QuestionnairesmedicineHumansAgedChi-Square Distributionbusiness.industryPatient SelectionMiddle Agedmedicine.diseasenervous system diseasesSubthalamic nucleussurgical procedures operativenervous systemNeurologyCAPSIT; Parkinson's disease; Questionnaire; STN DBS; Adult; Aged; Chi-Square Distribution; Deep Brain Stimulation; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Subthalamic Nucleus; Surveys and Questionnaires; Patient Selection; Aging; Neurology (clinical); NeurologyPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptomGeriatrics and GerontologyPsychologybusinesstherapeuticsNeuroscienceNeurology; Geriatrics and Gerontology; Neurology (clinical)
researchProduct